CAPR
Capricor Therapeutics, Inc.
23.07
2 x 17.28
2 x 29.55
bid
ask
-
1.01
4.19%
2 @ 08:58 AM
23.50 +0.43 (1.86%)
| Ytd | -20.06% | |
| 1y | 137.84% |
23.04
day range
24.25
4.30
52 week range
40.37
| Open | 24.05 | Prev Close | 24.08 | Low | 23.04 | High | 24.25 | Mkt Cap | 1.34B |
| Vol | 1.78M | Avg Vol | 1.15M | EPS | -2.32 | P/E | N/A | Forward P/E | -35.92 |
| Beta | 0.37 | Short Ratio | 13.95 | Inst. Own | 59.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 29.50 | 200-d Avg | 22.21 | 1yr Est | 53.60 |
| Income Statement | |||
| Operating Expenses | 36.77M | ||
| Research and Development Expense | 27.38M | ||
| Selling, General and Administrative Expense | 9.40M | ||
| Operating Income | -36.77M | ||
| Net Income | -33.94M | ||
| Net Income Common Stock | -33.94M | ||
| Net Income Common Stock (USD) | -33.94M | ||
| Consolidated Income | -33.94M | ||
| Earnings per Basic Share | -0.59 | ||
| Earnings per Basic Share (USD) | -0.59 | ||
| Earnings per Diluted Share | -0.59 | ||
| Earning Before Interest & Taxes (EBIT) | -33.94M | ||
| Earning Before Interest & Taxes (USD) | -33.94M | ||
| Weighted Average Shares | 57.43M | ||
| Weighted Average Shares Diluted | 57.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 105.42M | ||
| Cash and Equivalents (USD) | 105.42M | ||
| Investments | 173.19M | ||
| Investments Current | 173.19M | ||
| Current Assets | 283.09M | ||
| Property, Plant & Equipment Net | 41.66M | ||
| Total Assets | 326.28M | ||
| Debt Current | 841.14K | ||
| Total Debt | 14.78M | ||
| Current Liabilities | 33.64M | ||
| Debt Non-Current | 13.94M | ||
| Total Liabilities | 47.58M | ||
| Accumulated Retained Earnings (Deficit) | -338.82M | ||
| Accumulated Other Comprehensive Income | -253.73K | ||
| Shareholders Equity | 278.70M | ||
| Shareholders Equity (USD) | 278.70M | ||
| Assets Non-Current | 43.19M | ||
| Total Debt (USD) | 14.78M | ||
| Deferred Revenue | 12.00M | ||
| Liabilities Non-Current | 13.94M | ||
| Trade and Non-Trade Payables | 3.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 534.67K | ||
| Net Cash Flow from Financing | 1.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -182.43M | ||
| Capital Expenditure | -10.75M | ||
| Issuance (Purchase) of Equity Shares | 1.47M | ||
| Net Cash Flow from Investing | -154.64M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -143.89M | ||
| Net Cash Flow from Operations | -29.25M | ||
| Share Based Compensation | 5.92M | ||